This guide provides a central source of information on drug-drug interactions involving antiretroviral medications to assist healthcare providers in preventing or managing drug-drug interactions that could have a negative or dangerous effect on patient health. It can also help clinicians to identify drug-drug interactions that should or must be avoided and those that can be managed to alleviate adverse outcomes.
The Vanguard of HIV Care: Don't Forget This Screening
Bruce E. Hirsch, MD
[Excerpt] Today, the cutting edge of clinical care overlaps with primary care. The clinical vanguard addresses the medical vulnerabilities of patients with HIV, seeking to eliminate preventable morbidity and premature death. Among this clinical vanguard is the screening for and prevention ofanal cancer. With the increased longevity of people living with HIV and the nearly universal exposure to human papilloma virus (HPV), there is now potential for progression to mucosal cellular dysplasia and eventual malignancy. . .
Comment? Question? Suggestion?Drop us a line: firstname.lastname@example.org We welcome feedback and suggestions, and if you send us a question, we will get back to you as quickly as possible. Please note, however, that we cannot answer questions about the care or treatment of specific patients and cannot provide clinical advice.